Novo Nordisk A Slash S

Novo Nordisk A Slash S's reported carbon emissions

Novo Nordisk A/S, a pharmaceutical preparation manufacturer headquartered in Denmark, has demonstrated a strong commitment to reducing its environmental impact. In 2025, the company reported a total of approximately 2.69 billion kg CO2e in emissions. This figure is comprised of roughly 120 million kg CO2e from Scope 1 emissions and approximately 63 million kg CO2e from Scope 2 emissions (market-based). Scope 3 emissions represented the largest portion, totalling around 2.51 billion kg CO2e, with purchased goods and services being a significant contributor. Novo Nordisk has established ambitious climate targets. The company is aiming for net-zero emissions across its entire value chain by 2045. To support this long-term goal, they have set a near-term target to reduce Scope 3 CO2e emissions by 33% by 2033, using 2024 as the base year. Furthermore, Novo Nordisk has committed to achieving zero CO2e emissions from its operations and transportation by 2030, a target that aligns with the Science Based Targets initiative (SBTi) for limiting global warming to 1.5°C. The company also aims to ensure that its key suppliers, representing two-thirds of its Scope 3 emissions, will have their own GHG reduction targets in place by 2030.